DePuy Synthes, a division of Johnson & Johnson Medical Devices Companies, has introduced the new Concorde Lift Expandable Interbody Device in the US for the treatment of degenerative disc disease.
The implant is part of the company’s new Unleash MIS TLIF (Transforaminal Lumbar Interbody Fusion) Procedural Solution designed for minimally invasive spine surgery.
This procedural system additionally comprises the Concorde Clear MIS Discectomy Device and the Viper Prime System for percutaneous pedicle screw insertion.
It is intended to simplify certain stages of minimally invasive spine surgery and increase its efficiency.
DePuy Synthes Spine worldwide president Nadav Tomer said: “This Unleash Solution delivers a new offering to help reduce the complexity associated with minimally invasive spine surgery while reducing costs and OR footprint.
“DePuy Synthes is committed to innovating the tools and technology required to serve more patients globally in a range of care settings by delivering disruptive procedural solutions that improve outcomes supported by real-world clinical and economic evidence.”
Concorde Lift can be implanted during a spinal fusion surgery, where the degenerated disc is replaced with the device in order to restore the disc height amongst the two spinal vertebrae.
The implantation is preceded by the degenerated disc-clearing process using Concorde Clear MIS Discectomy Device, which is said to require fewer instrument passes and removes more disc material.
Viper Prime System is used during the last stage of the procedure to combine various instruments into a single screw inserter tool, thereby allowing insertion of the percutaneous pedicle screw in a single instrument pass.
Together, the Unleash MIS TLIF devices are expected to minimise surgical complexity, enhance patient outcomes and reduce costs.